Pfizer Partners with Quotient Therapeutics for Somatic Mutations Research in Cardiovascular and Renal Diseases
NEW YORK—Pfizer Inc., a pharmaceutical giant listed on the New York Stock Exchange (NYSE: PFE),...
NEW YORK—Pfizer Inc., a pharmaceutical giant listed on the New York Stock Exchange (NYSE: PFE),...
LONDON—Mundipharma International Ltd., the UK-based pharmaceutical firm with ties to the Sackler family of the...
CHENGDU—Leaderna Therapeutics Ltd, a pioneering nucleic acid drug developer, has reportedly secured nearly RMB 100...
Tigermed, a prominent Contract Research Organization (CRO) with a presence in both Shenzhen (SHE: 300347)...
Peijia Medical Ltd (HKG: 9996) has entered into a licensing agreement with NowYon Medical, securing...
Nanjing-based Frontier Biotechnologies Inc. is poised to divest a 70% stake in its peptide active...
Shanghai BDgene Technology Co., Ltd, a leading gene therapy specialist based in China, has entered...
China-based WORK Medical Technology Group Ltd has priced its initial public offering (IPO) at USD...
Shenzhen Salubris Pharmaceuticals Co., Ltd, a Chinese pharmaceutical company listed on the Shenzhen Stock Exchange...
Guangzhou Boji Medical Biotechnological Co., Ltd, a Clinical Research Organization (CRO) based in China and...
Shanghai Fosun Pharmaceutical (Group) Co., Ltd, listed on the Shanghai Stock Exchange (SHA: 600196) and...
Ensurge, a cutting-edge medical device manufacturer headquartered in Suzhou, is reportedly in the spotlight for...
ImmuneOnco Biopharmaceuticals (Shanghai) Co., Ltd (HKG: 1541) has received a USD 10 million upfront payment...
Ocumension Therapeutics, a biopharmaceutical company based in China and listed on the Hong Kong Stock...
Novartis (NYSE: NVS), a Swiss pharmaceutical heavyweight, has joined forces with the US venture capital...
Gulf Scientific Corporation (GSC), a prominent life sciences service provider headquartered in Dubai, United Arab...
Changchun GeneScience Pharmaceutical Co., Ltd, a Chinese pharmaceutical enterprise, has established a partnership with HuChuang...
SynthAsia has forged a strategic partnership with Shanghai General Hospital, focusing on scientific innovation within...
Shanghai Henlius Biotech Inc., (HKG: 2696), a leading biopharmaceutical company based in China, has entered...
Bone Index, a Finland-based medical technology company specializing in bone diagnostics, has announced the successful...